Stoke Therapeutics Inc

Company Snapshot
45 Wiggins Avenue
Bedford, MA 01730
United States
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 117
https://www.stoketherapeutics.com
Please select from the dropdown
Company Financials

2020
2021
2022
Gross Profit
Operating Income
($53,044,000)
($86,065,000)
($104,356,000)
Net Income
($52,243,000)
($85,805,000)
($101,067,000)
2020
Gross Profit
Operating Income
($53,044,000)
Net Income
($52,243,000)
2021
Gross Profit
Operating Income
($86,065,000)
Net Income
($85,805,000)
2022
Gross Profit
Operating Income
($104,356,000)
Net Income
($101,067,000)
The above data on Stoke Therapeutics Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Edward Kaye
Chief Executive Officer and Director
$919,012
$4,817,310
$12,200
$5,748,522
Edward Kaye
$5,748,522
Chief Executive Officer and Director
Barry Ticho
Chief Medical Officer
$677,842
$1,697,431
$10,984
$2,386,257
Barry Ticho
$2,386,257
Chief Medical Officer
Stephen Tulipano
Chief Financial Officer and Principal Accounting Officer
$608,900
$1,697,431
$10,192
$2,316,523
Stephen Tulipano
$2,316,523
Chief Financial Officer and Principal Accounting Officer
Arthur Tzianabos
Independent Director
$57,500
$169,140
$0
$226,640
Arthur Tzianabos
$226,640
Independent Director
Jennifer Burstein
Independent Director
$55,000
$169,140
$0
$224,140
Jennifer Burstein
$224,140
Independent Director
Stoke Therapeutics Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2022. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us